Cargando…
New Insights and Emerging Therapeutic Approaches in Prostate Cancer
Prostate cancer is the second most frequently diagnosed cancer in men and several therapeutic approaches are currently available for patient’s care. Although the androgen receptor status represents a good predictor of response to androgen deprivation therapy, prostate cancer frequently becomes resis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873523/ https://www.ncbi.nlm.nih.gov/pubmed/35222290 http://dx.doi.org/10.3389/fendo.2022.840787 |
_version_ | 1784657485647314944 |
---|---|
author | Licitra, Fabrizio Giovannelli, Pia Di Donato, Marzia Monaco, Alessandra Galasso, Giovanni Migliaccio, Antimo Castoria, Gabriella |
author_facet | Licitra, Fabrizio Giovannelli, Pia Di Donato, Marzia Monaco, Alessandra Galasso, Giovanni Migliaccio, Antimo Castoria, Gabriella |
author_sort | Licitra, Fabrizio |
collection | PubMed |
description | Prostate cancer is the second most frequently diagnosed cancer in men and several therapeutic approaches are currently available for patient’s care. Although the androgen receptor status represents a good predictor of response to androgen deprivation therapy, prostate cancer frequently becomes resistant to this approach and spreads. The molecular mechanisms that contribute to progression and drug-resistance of this cancer remain still debated. However, few therapeutic options are available for patient’s management, at this stage. Recent years have seen a great expansion of the studies concerning the role of stromal-epithelial interactions and tumor microenvironment in prostate cancer progression. The findings so far collected have provided new insights into diagnostic and clinical management of prostate cancer patients. Further, new fascinating aspects concerning the intersection of the androgen receptor with survival factors as well as calcium channels have been reported in cultured prostate cancer cells and mouse models. The results of these researches have opened the way for a better understanding of the basic mechanisms involved in prostate cancer invasion and drug-resistance. They have also significantly expanded the list of new biomarkers and druggable targets in prostate cancer. The primary aim of this manuscript is to provide an update of these issues, together with their translational aspects. Exploiting the power of novel promising therapeutics would increase the success rate in the diagnostic path and clinical management of patients with advanced disease. |
format | Online Article Text |
id | pubmed-8873523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88735232022-02-26 New Insights and Emerging Therapeutic Approaches in Prostate Cancer Licitra, Fabrizio Giovannelli, Pia Di Donato, Marzia Monaco, Alessandra Galasso, Giovanni Migliaccio, Antimo Castoria, Gabriella Front Endocrinol (Lausanne) Endocrinology Prostate cancer is the second most frequently diagnosed cancer in men and several therapeutic approaches are currently available for patient’s care. Although the androgen receptor status represents a good predictor of response to androgen deprivation therapy, prostate cancer frequently becomes resistant to this approach and spreads. The molecular mechanisms that contribute to progression and drug-resistance of this cancer remain still debated. However, few therapeutic options are available for patient’s management, at this stage. Recent years have seen a great expansion of the studies concerning the role of stromal-epithelial interactions and tumor microenvironment in prostate cancer progression. The findings so far collected have provided new insights into diagnostic and clinical management of prostate cancer patients. Further, new fascinating aspects concerning the intersection of the androgen receptor with survival factors as well as calcium channels have been reported in cultured prostate cancer cells and mouse models. The results of these researches have opened the way for a better understanding of the basic mechanisms involved in prostate cancer invasion and drug-resistance. They have also significantly expanded the list of new biomarkers and druggable targets in prostate cancer. The primary aim of this manuscript is to provide an update of these issues, together with their translational aspects. Exploiting the power of novel promising therapeutics would increase the success rate in the diagnostic path and clinical management of patients with advanced disease. Frontiers Media S.A. 2022-02-11 /pmc/articles/PMC8873523/ /pubmed/35222290 http://dx.doi.org/10.3389/fendo.2022.840787 Text en Copyright © 2022 Licitra, Giovannelli, Di Donato, Monaco, Galasso, Migliaccio and Castoria https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Licitra, Fabrizio Giovannelli, Pia Di Donato, Marzia Monaco, Alessandra Galasso, Giovanni Migliaccio, Antimo Castoria, Gabriella New Insights and Emerging Therapeutic Approaches in Prostate Cancer |
title | New Insights and Emerging Therapeutic Approaches in Prostate Cancer |
title_full | New Insights and Emerging Therapeutic Approaches in Prostate Cancer |
title_fullStr | New Insights and Emerging Therapeutic Approaches in Prostate Cancer |
title_full_unstemmed | New Insights and Emerging Therapeutic Approaches in Prostate Cancer |
title_short | New Insights and Emerging Therapeutic Approaches in Prostate Cancer |
title_sort | new insights and emerging therapeutic approaches in prostate cancer |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873523/ https://www.ncbi.nlm.nih.gov/pubmed/35222290 http://dx.doi.org/10.3389/fendo.2022.840787 |
work_keys_str_mv | AT licitrafabrizio newinsightsandemergingtherapeuticapproachesinprostatecancer AT giovannellipia newinsightsandemergingtherapeuticapproachesinprostatecancer AT didonatomarzia newinsightsandemergingtherapeuticapproachesinprostatecancer AT monacoalessandra newinsightsandemergingtherapeuticapproachesinprostatecancer AT galassogiovanni newinsightsandemergingtherapeuticapproachesinprostatecancer AT migliaccioantimo newinsightsandemergingtherapeuticapproachesinprostatecancer AT castoriagabriella newinsightsandemergingtherapeuticapproachesinprostatecancer |